Applied Therapeutics, Inc.
APLTDelisted Feb 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001697532
Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Applied Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 36 | 40 | +4 |
| Shares | 19.3M | 31.5M | +12.2M (+63.2%) |
| Value | $15.6M | $40.3M | +$24.6M (+157.6%) |
New holders (7)
Institutions that held Applied Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| VR Adviser, LLC | 5,658,034 | $7.24M | 1.16% |
| CM Management, LLC | 300,000 | $384.0K | 0.37% |
| Charles Schwab Investment Management Inc | 24,504 | $31.4K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 14,304 | $18.3K | 0.00% |
| Belvedere Trading LLC | 8,602 | $11.0K | 0.00% |
| Citadel Advisors LLC | 8,531 | $10.9K | 0.00% |
| Rhumbline Advisers | 544 | $696 | 0.00% |
Sold out (3)
Institutions that held Applied Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Citigroup Inc | 353,138 | $286.4K |
| Acadian Asset Management LLC | 47,495 | $38.0K |
| Virtu Financial LLC | 14,497 | $12.0K |